Literature DB >> 6425703

Rat climbing behavior elicited by stimulation of cerebral dopamine receptors.

P Protais, J J Bonnet, J Costentin, J C Schwartz.   

Abstract

The experimental conditions allowing to elicit by administration of dopamine agonists a climbing behavior in rats, apparently analogous to the stereotyped cage climbing behavior previously described in mice (Protais et al. 1976), have been established. Among the various strains of rats studied i.e. Sprague-Dawley, Long Evans and Wistar, the latters were selected as the most responsive to the dopamine agonist apomorphine. However, even in the Wistar strain, only about 60% of animals responded to a test-dose of 0.4 mg/kg apomorphine by adopting in a sustained manner the typical upright position against the walls of a suitable experimental cage. Hence responsive rats were preselected 4 days before the experimental sessions and finally rated during a 60-min observation period. Increasing the test-dose of apomorphine led to a biphasic effect, the spontaneous climbing behavior being decreased at low dosage and, then, both the percentage of climbing animals and the duration of the behavior were progressively increased at higher dosages. A scoring system based on an all-or-none evaluation of the frequency of stereotyped climbing episodes over the 1 h observation period was finally adopted allowing to establish dose response curves to apomorphine and its more potent derivative N-propylnorapomorphine. Dexamphetamine (associated to L-Dopa) also produced the stereotyped climbing behavior. The latter was completely abolished in animals treated with the "atypical" antipsychotic sulpiride. The effects of lesioning various cerebral dopaminergic areas on the apomorphine-induced behavior were investigated. The response was not significantly altered following bilateral thermocoagulations of the striatum (restricted lesions), globus pallidus, nucleus interstitialis of the striae terminalis, amygdala, nucleus lateralis septi or nucleus accumbens.(ABSTRACT TRUNCATED AT 250 WORDS)

Entities:  

Mesh:

Substances:

Year:  1984        PMID: 6425703     DOI: 10.1007/bf00506188

Source DB:  PubMed          Journal:  Naunyn Schmiedebergs Arch Pharmacol        ISSN: 0028-1298            Impact factor:   3.000


  31 in total

1.  Long-term changes in the sensitivity of pre-and postsynaptic dopamine receptors in mouse striatum evidenced by behavioural and biochemical studies.

Authors:  M P Martres; J Costentin; M Baudry; H Marcais; P Protais; J C Schwartz
Journal:  Brain Res       Date:  1977-11-11       Impact factor: 3.252

2.  Effect of L-histidine and chlorcyclizine on apomorphine-induced climbing behaviour and methamphetamine stereotypy in mice.

Authors:  V V Joshi; J J Balsara; J H Jadhav; A G Chandorkar
Journal:  Eur J Pharmacol       Date:  1981-02-19       Impact factor: 4.432

3.  Narcotic analgesics and stereotyped behaviour in mice.

Authors:  R Langwiński; J Niedzielski
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1980-07       Impact factor: 3.000

4.  Changes in dopamine receptors in mouse striatum following morphine treatments.

Authors:  S de la Baume; G Patey; H Marçais; P Protais; J Costentin; J C Schwartz
Journal:  Life Sci       Date:  1979-06-18       Impact factor: 5.037

5.  Rapid development of hypersensitivity of striatal dopamine receptors induced by alpha-methylparatyrosine and its prevention by protein synthesis inhibitors.

Authors:  J Costentin; H Marçais; P Protais; M Baudry; S De La Baume; M P Martres; J C Schwartz
Journal:  Life Sci       Date:  1977-08-01       Impact factor: 5.037

6.  Hypersensitivity of the climbing behaviour response to apomorphine induced by a short depression of dopaminergic neurone activity.

Authors:  H Marcais; P Protais; J Costentin
Journal:  Neuropharmacology       Date:  1979-11       Impact factor: 5.250

7.  Central catecholamine neuron systems: anatomy and physiology of the dopamine systems.

Authors:  R Y Moore; F E Bloom
Journal:  Annu Rev Neurosci       Date:  1978       Impact factor: 12.449

8.  Dopamine antagonist properties of atypical neuroleptics may be revealed following mesolimbic denervation.

Authors:  V Nohria; B Costall; R J Naylor
Journal:  Int Pharmacopsychiatry       Date:  1981

9.  Subsensitivity of striatal and mesolimbic dopamine target cells after repeated treatment with apomorphine dipivaloyl ester.

Authors:  B Scatton; P Worms
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1978-07       Impact factor: 3.000

10.  Effects of cholecystokinin octapeptide on striatal dopamine metabolism and on apomorphine-induced stereotyped cage-climbing in mice.

Authors:  G L Kovács; G Szabó; B Penke; G Telegdy
Journal:  Eur J Pharmacol       Date:  1981-01-29       Impact factor: 4.432

View more
  6 in total

1.  Appearance of a stereotyped apomorphine-induced climbing in unresponsive DBA2 mice after subchronic manipulations of brain dopamine transmission.

Authors:  D Duterte-Boucher; J Costentin
Journal:  Psychopharmacology (Berl)       Date:  1989       Impact factor: 4.530

2.  Unexpected potentiation by discriminant benzamide derivatives of stereotyped behaviours elicited by dopamine agonists in mice.

Authors:  M Vasse; P Protais; J Costentin; J C Schwartz
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1985-04       Impact factor: 3.000

3.  Selection of dopamine antagonists discriminating various behavioral responses and radioligand binding sites.

Authors:  M P Martres; P Sokoloff; M Delandre; J C Schwartz; P Protais; J Costentin
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1984-02       Impact factor: 3.000

4.  Dopamine agonist action in mesolimbic, cortical and extrapyramidal areas to modify spontaneous climbing behaviour of the mouse.

Authors:  B Costall; J F Eniojukan; R J Naylor
Journal:  Psychopharmacology (Berl)       Date:  1985       Impact factor: 4.530

5.  A comparison of motor behaviours in groups of rats distinguished by their climbing response to apomorphine.

Authors:  A S Davis; P Jenner; C D Marsden
Journal:  Br J Pharmacol       Date:  1986-01       Impact factor: 8.739

6.  Differential ability of selective and non-selective dopamine agonists to induce climbing in the rat indicates the involvement of both D-1 and D-2 receptors in this behaviour.

Authors:  A Davis; P Jenner; C D Marsden
Journal:  Psychopharmacology (Berl)       Date:  1990       Impact factor: 4.530

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.